This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Resoloy Initial Safety Evaluation | MicrobiomeTrials
← Back to trials NCT07648017
Resoloy Initial Safety Evaluation Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-08-23Est. Completion: 2026-12-01
Enrollment target: 10 participantsLocations Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation (clinical base "Nano Medical Clinic" at "GARBUS TRADE" JV LLC), Tashkent, Uzbekistan Other microbiome trials you might be interested in CLTI Defined as Rutherford Category 4 or 5
Chronic limb threatening ischemia (CLTI) is defined as ischemic foot pain at rest or non-healing foot wounds that is att…
Multiple Locations Est. completion May 30, 2030
Peripheral Arterial Disease Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (u…
Chandler, United States Est. completion Jun 1, 2027